Health News Releases

  • Today April 23
November 13, 2024 11:35
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion
November 13, 2024 10:55
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that IDEAYA Biosciences, Inc.
Novotech and Biostar Pharma Partnership (Photo: Business Wire)
November 13, 2024 08:58
Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
November 12, 2024 15:38
Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
Merck, a leading science and technology company, today announced that the Phase III MANEUVER trial of pimicotinib, an investigational medicine being developed by Abbisko Therapeutics Co., Ltd., met it
November 12, 2024 10:30
Huonslab reinforces HyDIFFUZE™ (Recombinant human hyaluronidase PH20) Intellectual Property by completing the US and EU Examination Request under PCT application.
Huonslab, Co. Ltd. (https://huonslab.com/layout/eng/home.php?go=main&) S. Korea, a subsidiary of Huons Global (https://huonsglobal.com/eng/home.php) (KOSDAQ:084110) and a global leader in recombinant
2024 Clinical Trials Arena Excellence Award Winner Presented to Novotech (Graphic: Business Wire)
November 12, 2024 09:45
Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards
Novotech, the global full-service clinical Contract Research Organization (CRO), has received multiple awards in the 2024 Clinical Trials Arena Excellence Awards, recognizing the achievements of our p
November 08, 2024 16:10
Huons Speeds up Biopharmaceutical Development with Human-Derived Hyaluronidase and Expands Bio-Pharma Business by Acquiring Stake in PanGen
Huons Co., Ltd. (https://www.huons.com/eng/home.php?go=main)(KRX:243070) (Co-CEOs : Song Soo-young and Yoon Sang-bae) announced on November 5 that it has decided to acquire 2,647,378 shares of PanGen
SBC Medical Group Holdings Incorporated, a global owner, operator and provider of management service
November 08, 2024 15:15
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”, or the “Company”, or “SBC”), a global owner, operator and provider of management services and products to cosmetic treatment cente
November 07, 2024 10:15
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Brut
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award (Phot
November 06, 2024 15:10
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award
Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services (RPM), the largest pre-hospital care and emergency medical services provider in t
November 05, 2024 16:15
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Evercode™ Low Input Fixation kits (https://cts.busines
November 05, 2024 15:10
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto.) (TOKYO:4151) today announced that Masashi Miyamoto, Ph.D. will take the role of Chairma
November 04, 2024 16:55
Celebrating 25 Years of Sculptra®: New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation
This month marks the 25th anniversary of the approval of Sculptra®, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation.[1-5,10-16]Sculptra works with
November 03, 2024 11:30
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.medidata.com&esheet=54145051&newsitemid=20241031324962&lan=en-US&anchor=Medidata&index=1&md5=ae204c6a0f9fac4adb7ac338e882
(Photo: Business Wire)
November 03, 2024 10:45
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establ
November 03, 2024 10:30
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54142153&newsitemid=20241030235134&lan=en-US&anc
Rob Wojciechowski (Photo: Business Wire)
November 01, 2024 16:10
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the appointment of Rob Wojciechowski as Managing Director of the Consulting Practice across Europe and the Asia-
November 01, 2024 14:30
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fmedidata.com&esheet=54142421&newsitemid=20241029570790&lan=en-US&anchor=Medidata&index=1&md5=0177f87e5f8ba1d95a947b55a8ead5ee
October 31, 2024 09:13
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for HLX14, an investigatio
October 30, 2024 14:40
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54143515&newsitemid=20241029413584&lan=en-US&anchor=Parse+Biosciences&index=1&md
October 30, 2024 14:25
Naobios and Sumagen Successfully Optimize HIV Vaccine Candidate for Industrial Production
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, and Sumagen Canada Inc (Sumagen),
October 30, 2024 10:45
World Stroke Organization Launches Global Coalition to Drive Policy Action on Stroke Care
On World Stroke Day, October 29, the World Stroke Organization (WSO) announces the launch of a global coalition aimed at accelerating policy action on stroke—now the second leading cause of death and
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences
October 29, 2024 15:25
Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry
Boomi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fboomi.com%2F&esheet=54141438&newsitemid=20241028722622&lan=en-US&anchor=Boomi&index=1&md5=0797880acb2d3b33005b1492eb4e78bc)™, t
October 29, 2024 14:30
ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
ADx NeuroSciences, a wholly owned subsidiary of Fujirebio and a leader in neurodegenerative disease biomarker development, and Alamar Biosciences, a leader in ultra-sensitive immunoassay technologies,
October 29, 2024 13:50
BeiGene Mourns Death of Beloved Board Member Donald Glazer
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54142605&newsitemid=20241028061544&lan=en-US&anchor=BeiGene&index=1&md5=91bcb3b9baea32c9e4fd8e1120f
October 28, 2024 10:40
LabGenomics USA Concludes Acquisition of IMD CLIA Labs
LabGenomics USA (https://www.labgusa.com/) has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four. This ac
October 27, 2024 13:30
Listing on the Tokyo Stock Exchange Prime Market
Rigaku Holdings Corporation, a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), has completed its listing on the Tokyo Stock Excha
October 25, 2024 14:17
Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends
Galderma (SWX:GALD), the pure-play dermatology category leader, today announced a new edition of the Galderma Aesthetic Injector Network (GAIN) event in the Asia-Pacific region, which houses some of t
Boomi Launches New Veeva Vault Connector to Simplify Application Integration in the Life Sciences Industry
October 25, 2024 14:10
Boomi Launches New Veeva Vault Connector to Simplify Application Integration in the Life Sciences Industry
Boomi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fboomi.com%2F&esheet=54141433&newsitemid=20241024317066&lan=en-US&anchor=Boomi&index=1&md5=7d9b4c6f5795fffa95b058382b2d3658)™, t
October 25, 2024 11:38
Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first nine months of 2024, reporting record net sales and significant progress ac
October 24, 2024 10:00
BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issue
(Photo: Business Wire)
October 23, 2024 14:45
ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation
ANANDA Scientific Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.anandascientific.com%2F&esheet=54138297&newsitemid=20241022571870&lan=en-US&anchor=ANANDA+Scientific+Inc.&
October 21, 2024 17:20
ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™)
Galderma today announced new phase III data from the READY-4 clinical trial, demonstrating the long-term safety of RelabotulinumtoxinA (Relfydess™) for frown lines and crow’s feet after repeated injec
October 18, 2024 11:35
Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54136391&newsitemid=20241017355667&lan=en-US&anchor=Medidata&index=1&md5=d87912bb1e54e36a39a
Measuring 35x35cm, the material has been produced using the company’s newly scaled-up tissue bioreac
October 17, 2024 14:45
Bio-Engineering Scale-Up Qorium Showcases Cultivated Leather Breakthrough, Signalling a Key Step Towards Commercialisation
Cultivated leather pioneer Qorium has released footage (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fvimeo.com%2F1017020585%3Fshare%3Dcopy%23t%3D0&esheet=54135213&newsitemid=20241
(Photo: Business Wire)
October 17, 2024 14:30
ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain
ANANDA (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fanandascientific.com%2F&esheet=54135042&newsitemid=20241015941899&lan=en-US&anchor=ANANDA&index=1&md5=44a7f5c1680156e5b97b89ec
Top 10 finalist nurses for Aster Guardians Global Nursing Award 2024 (Photo: AETOSWire)
October 17, 2024 14:25
Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2024
Aster Guardians Global Nursing Award has today unveiled the top 10 finalists for 2024, one of whom will go on to win the grand title award of US $ 250,000. These 10 nurses have been shortlisted from a
October 14, 2024 16:00
Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®, receives approval from US FDA
Dong-A ST (http://en.donga-st.com/Main.da) (President/CEO Jae-Hun Jung, KRX: 170900) announced on October 11 that Imuldosa™ (usteki-numab-srlf/DMB-3115), a biosimilar referencing Stelara®, has won U.S
Avania, the leading, global medical technology contract research organization and advisory services
October 09, 2024 14:10
Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography
Avania (https://www.avaniaclinical.com/), the leading, global medical technology contract research organization (CRO) and advisory services partner, today announced its acquisition of Anagram (https:/
October 09, 2024 12:25
EU Notified Body (BSI Netherlands) and the EMA Grant Approval of the LeukoStrat® CDx FLT3 Mutation Assay for VANFLYTA® Therapy in the EU and EEA
Invivoscribe is excited to announce that their CE-2797 IVD certified LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI (Netherlands) and the EMA to aid in the selection of individuals in th
A radiologist looking at MRI exam images (Photo: Business Wire)
October 08, 2024 08:37
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
GE HealthCare (Nasdaq: GEHC) has today announced the completion of its Phase I clinical development program for a first-of-its-kind manganese-based macrocyclic magnetic resonance imaging (MRI) contras
October 04, 2024 16:50
Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
Ferring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin® (nado
October 02, 2024 13:45
Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
Crown Bioscience (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.crownbio.com%2F&esheet=54128719&newsitemid=20241001076209&lan=en-US&anchor=Crown+Bioscience&index=1&md5=d0a4aa1a
AOP Health CEO Martin Steinhart (Copyright: AOP Health/Studio Koekart)
October 02, 2024 13:45
Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells
AOP Orphan Pharmaceuticals GmbH (AOP Health) in collaboration with Leukos Biotech has achieved a key milestone. The first patient was included in the phase I clinical trial SERONCO-1, in which a subst
October 02, 2024 09:42
Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study
Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) approach based on faecal calprotectin (FC)
Novotech is a Great Place to Work Certified in the USA (Graphic: Business Wire)
October 01, 2024 15:25
Novotech Earns Great Place to Work® Certification in the United States
Novotech, a global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been certified as a Great Place to Work® in the United States. This award reflects Novot
October 01, 2024 11:20
SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production
SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a major expansion of its small molecule and peptide production capabilities with a $260 million inves
September 27, 2024 14:19
Global Oncology Innovator BeiGene Appoints Shalini Sharp to Board of Directors
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54127370&newsitemid=20240926501587&lan=en-US&anchor=BeiGene&index=1&md5=35ef0ca3f29c557d3fdea29b228
Logo
September 26, 2024 16:40
Merz Aesthetics Announces the Launch of Ultherapy PRIME Platform as the Next Generation of Nonsurgical Skin Lifting Treatments
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of Ultherapy PRIME - a noninvasive, FDA-cleared medical aesthetics treatment that provides a trul
PCI Pharma Services is investing more than $365 million in infrastructure supporting the clinical an
September 26, 2024 14:25
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
PCI Pharma Services, (“PCI”) a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastru
25 per page50 per page75 per page100 per page